Bio-Techne Showcases Breakthrough Solutions at Neuroscience 2024
Bio-Techne's Commitment to Neuroscience Research
Bio-Techne Corporation (NASDAQ: TECH) is gearing up for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. This prestigious event is set to take place October 5-9 in Chicago, where Bio-Techne is prepared to showcase advancements that are shaping the future of neuroscience research.
Innovative Solutions on Display
At booth #1165, attendees can explore Bio-Techne's impressive lineup of life science reagents and analytical instruments. This includes cutting-edge immunoassays and multiomics solutions designed for streamlining the research process. These tools are set to enhance biomarker discovery, optimize neural cell cultures, and innovate drug screening methodologies.
Highlighting Key Presentations and Technologies
During the event, Bio-Techne will host a nanosymposium focusing on the pivotal topic of senescence in the aging brain. This discussion will feature the RNAscope™ Multiomic LS assay, which facilitates high-throughput spatial analysis for complex biological systems. Additionally, a poster presentation will underline the company's commitment to antibody validation using the hyperplex spatial biology platform from Lunaphore, enhancing research accuracy.
Collaboration Spotlight with FUJIFILM Cellular Dynamics
In collaboration with FUJIFILM Cellular Dynamics, Bio-Techne is set to deliver a Product Theater presentation. The focus will be on intracellular signaling in Alzheimer's disease, emphasizing Simple Western™ automated western technology. This innovative technology allows for protein size characterization directly from complex samples such as tissue or cell lysates, demonstrating a significant advancement in neurobiological research tools.
Scientific Presentations at the Conference
Bio-Techne's involvement in Neuroscience 2024 extends to several pivotal presentations, including:
- Simple Western™ Capillary Immunoassays: A groundbreaking approach to elucidating intracellular signaling in Alzheimer's disease, presented on October 7 at 2:30 pm.
- Investigating Hallmarks of Senescence: A presentation on October 9, detailing the use of a novel RNA-Protein Multiomic Co-Detection Assay.
- Automated Assay for Precise pTau217 Quantification: Scheduled for October 6, showcasing techniques that enhance sensitivity in disease markers detection.
- Bridging Synaptic Research: Highlighting interactions between neurexin and neuroligin on October 6, leveraging multiomic RNAscope technology for detailed studies.
- Spatial Multiomic Assay Analysis: Set for October 8, focusing on interneuron heterogeneity in the brain.
Furthermore, a collaborative presentation on characterizing iPSC-derived human microglial activation will showcase the integration of various advanced technologies in neuroinflammation research.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) is a leader in life sciences, providing innovative tools and reagents essential for research and clinical diagnostics. With a rich portfolio comprising hundreds of thousands of products, Bio-Techne supports scientific exploration into biological mechanisms and disease progression. They help propel drug discovery and aid in developing accurate diagnostic tests. In the last fiscal year, Bio-Techne reported approximately $1.2 billion in net sales and employs around 3,100 professionals globally.
Frequently Asked Questions
What will Bio-Techne present at Neuroscience 2024?
Bio-Techne will showcase its innovative life science solutions, emphasizing tools for neurological research and advancements in biomarker discovery.
Where will the event take place?
The Neuroscience 2024 annual meeting will occur in Chicago, from October 5-9, focusing on the latest findings in neuroscience.
What technologies will be highlighted?
Attendees can look forward to demonstrations of high-quality life science reagents, immunoassays, and spatial biology analysis techniques.
Who will represent Bio-Techne at the conference?
Key speakers, including Kim Kelderman, Bio-Techne's President and CEO, with leading scientists from FUJIFILM and Cell Signaling Technology, will present.
How can I learn more about Bio-Techne's offerings?
To explore Bio-Techne's innovative products and solutions for neuroscience and beyond, visit their official website.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- UAW Advocates for Strike Authorization Amid Contract Disputes
- Investigation Launched Into Acadia Healthcare Company: Insights
- Unlock Conservation Funding for Sustainable Farming Practices
- Cathie Wood's ARK ETFs Adjust Holdings: Roku and More
- Starbucks Investors Urged to Act Now for Class Action Participation
- Hurricane Helene's Impact: Estimated Losses Range from $3B to $5B
- AHF Celebrates HRSA's Defense of the 340B Drug Pricing Program
- Investigation Underway for Metagenomi Inc. Shareholders
- Sunrise Erectors Faces Data Breach Investigation After Alerts
- High Tide Inc. Celebrates Impressive Growth in Canada 2024
Recent Articles
- Green Check Empowers Indigenous Cannabis Ventures with Banking
- Vahe Dombalagian Takes Helm as Managing Partner at MDP
- DeshCap Elevates Business Insurance with Guaranteed Savings
- Draganfly's Commander 3XL Drones Advance Military Logistics
- Fractyl Health Set to Showcase Innovation at Key Conference
- Dana Unveils Innovative Reman Program to Enhance Sustainability
- Innovative Animal Feed Additives Development by NOVUS and Ginkgo
- Unicycive Therapeutics Shares Exciting Participation at Conference
- Garmin Celebrates a Decade as Top Marine Electronics Manufacturer
- Market Insights: Futures Boosted by China's Economic Measures
- ScottsMiracle-Gro Embraces AI for Enhanced Gardening Guidance
- Exploring the Rescue Journey of Monkeys at the Sanctuary
- Veeva Vault QMS Enhances Efficiency with New Features
- Veeva Vault QMS Introduces Enhanced Features for Medtech Industry
- Discover ALDI's Top Fan Favorites for 2024 and Beyond
- Averna Marks 25 Years as a Leading Test Solutions Provider
- Warner Bros. Discovery Enhances Captioning with AI Solutions
- Averna Marks 25 Years as a Global Leader in Quality Solutions
- Exciting Development of Cyngn's New DriveMod Tugger
- PUMA Teams Up with Google Cloud to Enhance Product Launching
- Baird Initiates Coverage of Procore Technologies with a Strong Outlook
- Goldman Sachs Reaffirms Buy for Boeing Amid Production Challenges
- Castellum, Inc. Secures Key $4.1M NSF Contract with Epic Systems
- Baird Issues Outperform Rating for ResMed Amidst Market Stability
- Cyderes Welcomes New CEO as Leadership Shifts in Cybersecurity
- Union Pacific: Navigating Challenges Amid Growth Opportunities
- Projected Growth of Peripheral Intravenous Catheters Market
- Concerns Rise Among Zimbabwean Retailers About Currency Impact
- Dock Leveler Market Growth Set to Reach $2.33 Billion by 2034
- FrontView REIT Set to Secure $277 Million in US IPO Launch
- Exploring Orderly Network's Innovations at TOKEN2049 Event
- Boost in Mining Stocks Driven by China's Stimulus Measures
- BRB Foods Set to Launch IPO for 2.6 Million Shares
- RAIR Technologies Joins Denarii Labs for Web3 Advancement
- Starbucks Faces Challenges After Downgrade Amid Leadership Change
- Freename's Ambitious Plans for ICANN Top-Level Domain Registration
- Can-Fite's Vetbiolix Agreement Projected to Generate $325M
- Visa Faces Legal Challenges Over Possible Monopoly in Debit Cards
- Canoo Launches Electric Vehicle Hub in the UK to Enhance Accessibility
- PayMate Expands Horizons with DigiAsia Acquisition Plans
- Foremost Lithium Partners with Denison for Uranium Ventures
- First Atlantic Nickel Advances Exploration with New Finds and Acquisition
- Village Farms Expands Presence by Acquiring Leli Holland Completely
- Tilray Brands Launches Groundbreaking Delta-9 THC Beverages
- Market Rally Sparks Optimism for Economic Growth Prospects
- AOI Unveils 1.6T OSFP DR8 LPO Module to Transform Networks
- Innovative Insights from Axsome Therapeutics at Key Sleep Conference
- W. P. Carey: A Strategic Shift Toward Growth and Stability
- Entrada Therapeutics Elevates Natarajan Sethuraman to New Role
- Innovative Growth Strategy of TAG in Solar Development Finance